Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains

Yerly Vargas-Casanova; Andrea Verónica Rodríguez-Mayor; Karen Johanna Cardenas; Aura Lucía Leal-Castro; Liliana Constanza Muñoz-Molina; Ricardo Fierro-Medina; Zuly Jenny Rivera-Monroy; Javier Eduardo García-Castañeda

doi:10.1039/c9ra00708c

Synergistic bactericide and antibiotic effects of dimeric, tetrameric, or palindromic peptides containing the RWQWR motif against Gram-positive and Gram-negative strains

RSC Adv. 2019 Mar 5;9(13):7239-7245. doi: 10.1039/c9ra00708c. eCollection 2019 Mar 1.

Authors

Yerly Vargas-Casanova¹, Andrea Verónica Rodríguez-Mayor², Karen Johanna Cardenas³, Aura Lucía Leal-Castro⁴, Liliana Constanza Muñoz-Molina⁵, Ricardo Fierro-Medina², Zuly Jenny Rivera-Monroy², Javier Eduardo García-Castañeda⁵

Affiliations

¹ Biotechnology Institute, Universidad Nacional de Colombia Carrera 45 No 26-85 Bogotá 11321 Colombia.
² Chemistry Department, Universidad Nacional de Colombia Carrera 45 No 26-85, Building 450, Office 213 Bogotá 11321 Colombia.
³ Pharmacy Department, Universidad Nacional de Colombia Carrera 45 No 26-85, Building 450, Office 213 Bogotá 11321 Colombia.
⁴ Medicine Faculty, Universidad Nacional de Colombia Carrera 45 No 26-85, Building 450, Office 213 Bogotá 11321 Colombia.
⁵ Universidad Colegio Mayor de Cundinamarca Calle 28 No. 5B-02 Bogotá 110311 Colombia jaegarciaca@unal.edu.co +57-1-3165000 extn 14436.

Abstract

Dimeric and tetrameric peptides derived from LfcinB (20-25): RRWQWR, LfcinB (20-30): RRWQWRMKKLG, LfcinB (17-31): FKARRWQWRMKKLGA, or the palindromic sequence LfcinB (21-25)_Pal: RWQWRWQWR were obtained by means of the SPPS-Fmoc/tBu methodology. The antibacterial activity of these molecules was evaluated against Escherichia coli (ATCC 25922 and ATCC 11775), Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853). The dimer LfcinB (20-25)₂: (RRWQWR)₂K-Ahx, the tetramer LfcinB (20-25)₄: (RRWQWR)₄K₂-Ahx₂-C₂, and the palindromic sequence LfcinB (21-25)_Pal exhibited the highest antibacterial activity against the tested bacterial strains. In all cases, the antibacterial activity was dependent on peptide concentration. The polyvalent molecules LfcinB (20-25)₂ and LfcinB (20-25)₄ exhibited bacteriostatic and bactericidal activity against E. coli, P. aeruginosa, and S. aureus strains; additionally, this dimer and this tetramer combined with ciprofloxacin exhibited a synergistic antibacterial effect against E. coli ATCC 25922 and P. aeruginosa, respectively. Furthermore, the peptides LfcinB (20-30)₄, LfcinB (20-25)₄, and LfcinB (21-25)_Pal combined with vancomycin exhibited a synergistic antibacterial effect against S. aureus and E. faecalis, respectively. This study showed that polyvalent peptides derived from LfcinB exhibit significant antibacterial activity, suggesting that these peptides could have a therapeutic application. Furthermore, our results suggest that polyvalent peptide synthesis could be considered as an innovative and viable strategy for obtaining promising antimicrobial molecules.